Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2020 Jun 16;10(6):375.
doi: 10.3390/brainsci10060375.

Psychiatric Manifestation of Anti-LGI1 Encephalitis

Affiliations
Case Reports

Psychiatric Manifestation of Anti-LGI1 Encephalitis

Dominique Endres et al. Brain Sci. .

Abstract

Background: Anti-leucine-rich glioma-inactivated 1 (LGI1) encephalitis is typically characterized by limbic encephalitis, faciobrachial dystonic seizures and hyponatremia. The frequency with which milder forms of anti-LGI1 encephalitis mimic isolated psychiatric syndromes, such as psychoses, or may lead to dementia if untreated, is largely unknown.

Case presentation: Here, the authors present a 50-year-old patient who had suffered from neurocognitive deficits and predominant delusions for over one and a half years. He reported a pronounced feeling of thirst, although he was drinking 10-20 liters of water each day, and he was absolutely convinced that he would die of thirst. Due to insomnia in the last five years, the patient took Z-drugs; later, he also abused alcohol. Two years prior to admission, he developed a status epilepticus which had been interpreted as a withdrawal seizure. In his serum, anti-LGI1 antibodies were repeatedly detected by different independent laboratories. Cerebrospinal fluid analyses revealed slightly increased white blood cell counts and evidence for blood-brain-barrier dysfunction. Magnetic resonance imaging showed hyperintensities mesio-temporally and in the right amygdala. In addition, there was a slight grey-white matter blurring. A cerebral [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) examination of his brain showed moderate hypometabolism of the bilateral rostral mesial to medial frontal cortices. Treatment attempts with various psychotropic drugs remained unsuccessful in terms of symptom relief. After the diagnosis of probable chronified anti-LGI1 encephalitis was made, two glucocorticoid pulse treatments were performed, which led to a slight improvement of mood and neurocognitive deficits. Further therapy was not desired by the patient and his legally authorized parents.

Conclusion: This case study describes a patient with anti-LGI1 encephalitis in the chronified stage and a predominant long-lasting psychiatric course with atypical symptoms of psychosis and typical neurocognitive deficits. The patient's poor response to anti-inflammatory drugs was probably due to the delayed start of treatment. This delay in diagnosis and treatment may also have led to the FDG-PET findings, which were compatible with frontotemporal dementia ("state of damage"). In similar future cases, newly occurring epileptic seizures associated with psychiatric symptoms should trigger investigations for possible autoimmune encephalitis, even in patients with addiction or other pre-existing psychiatric conditions. This should in turn result in rapid organic clarification and-in positive cases-to anti-inflammatory treatment. Early treatment of anti-LGI1 encephalitis during the "inflammatory activity state" is crucial for overall prognosis and may avoid the development of dementia in some cases. Based on this case, the authors advocate the concept-long established in many chronic inflammatory diseases in rheumatology-of distinguishing between an "acute inflammatory state" and a "state of organ damage" in autoimmune psychosis resembling neurodegenerative mechanisms.

Keywords: anti-LGI1 encephalitis; autoimmune psychosis; limbic encephalitis.

PubMed Disclaimer

Conflict of interest statement

D.E.: None. H.P.: None. A.D.: None. J.S.: None. B.F.: None. T.S.: None. N.V.: None. K.N.: None. S.M.: None. M.M.: None. S.J.M.: None. K.D.: Steering Committee Neurosciences, Janssen. H.U.: He is a shareholder of Veobrain GmbH. P.T.M.: None. L.T.v.E.: Advisory boards, lectures, or travel grants within the last three years: Roche, Eli Lilly, Janssen-Cilag, Novartis, Shire, UCB, GSK, Servier, Janssen and Cyberonics.

Figures

Figure 1
Figure 1
Clinical symptoms and course. Abbreviation: yrs, years.
Figure 2
Figure 2
Magnetic resonance imaging showing fluid-attenuated inversion recovery (FLAIR) hyperintensities right-mesio-temporally and on the right side of the corpus amygdaloideum, as well as a small, possibly microangiopathic, lesion in the left thalamus (bottom row). In addition, a slight grey–white matter blurring was observed (top center and right; cf. [8]).
Figure 3
Figure 3
A [18F] fluorodeoxyglucose positron emission tomography (FDG-PET) examination revealed moderate hypometabolism of the bilateral mesial to medial frontal cortices. Upper row: transaxial FDG-PET images (voxel-wise FDG uptake normalized to whole brain uptake); lower row: 3D surface projections of regions with decreased FDG uptake (color-coded Z-score, compared to age-matched healthy controls; minor, linear-shaped areas of mild hypometabolism were judged to be non-specific partial volume effects due to atrophy, whereas occipital cortex hypometabolism was probably caused by closing the eyes; [17]). The FDG-PET of the brain was performed 50 min after injection of 214 MBq FDG (Vereos Digital PET/CT, Philips Healthcare, The Netherlands). Abbreviations: R, right; l, left.

Similar articles

Cited by

References

    1. Van Sonderen A., Thijs R.D., Coenders E.C., Jiskoot L.C., Sanchez E., de Bruijn M.A., van Coevorden-Hameete M.H., Wirtz P.W., Schreurs M.W., Sillevis Smitt P.A., et al. Anti-LGI1 encephalitis: Clinical syndrome and long-term follow-up. Neurology. 2016;87:1449–1456. doi: 10.1212/WNL.0000000000003173. - DOI - PubMed
    1. Van Sonderen A., Petit-Pedrol M., Dalmau J., Titulaer M.J. The value of LGI1, Caspr2 and voltage-gated potassium channel antibodies in encephalitis. Nat Rev Neurol. 2017;13:290–301. doi: 10.1038/nrneurol.2017.43. - DOI - PubMed
    1. Dalmau J., Graus F. Antibody-Mediated Encephalitis. N. Engl. J. Med. 2018;378:840–851. doi: 10.1056/NEJMra1708712. - DOI - PubMed
    1. Graus F., Titulaer M.J., Balu R., Benseler S., Bien C.G., Cellucci T., Cortese I., Dale R.C., Gelfand J.M., Geschwind M., et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016;15:391–404. doi: 10.1016/S1474-4422(15)00401-9. - DOI - PMC - PubMed
    1. Van Sonderen A., Schreurs M.W., Wirtz P.W., Sillevis Smitt P.A., Titulaer M.J. From VGKC to LGI1 and Caspr2 encephalitis: The evolution of a disease entity over time. Autoimmun Rev. 2016;15:970–974. doi: 10.1016/j.autrev.2016.07.018. - DOI - PubMed

Publication types

LinkOut - more resources